Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) FDA drug shortages: Semaglutide injection, Food and Drug Administration FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) Ozempic, DailyMed (2024) Find out if your insurance covers Ozempic, Novo Nordisk FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Company statement: Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
This strategy is on full display in its award-winning campaign, We Heart Healthy Vaginas. Created by agency Oberland, the Valentines Day-themed campaign used playful packaging, reclaimed language, and merch like pH-balanced candy hearts to promote awareness of Wisps vaginal health offerings
These injections often use slightly longer needles and are ideal for therapies where faster uptake is beneficial
GLP-1 RAs* mimic everything your GLP-1 peptide hormone does: It ups the release of insulin, decreases the release of glucagon, delays gastric emptying, and increases satiety
